The epidemiology of sepsis

Current Pharmaceutical Design

Volumn 14, Issue 19, 2008, Pages 1833-1839

  Hodgin, Katherine E ^a   Moss, Marc ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

Epidemiology; Etiology; Gastrointestinal; Genitourinary; Gram positive bacteria; Organisms; Sepsis; Systemic inflammatory response syndrome (SIRS)

Indexed keywords

AGE DISTRIBUTION; ALCOHOL ABUSE; COMORBIDITY; DIABETES MELLITUS; DISEASE COURSE; DISEASE EXACERBATION; DISEASE SEVERITY; ETHNICITY; GASTROINTESTINAL INFECTION; GRAM NEGATIVE SEPSIS; HEALTH CARE COST; HOSPITAL INFECTION; HOSPITALIZATION COST; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; LUNG INFECTION; MORTALITY; MULTIPLE ORGAN FAILURE; NEOPLASM; PRIORITY JOURNAL; RACE DIFFERENCE; REVIEW; RISK FACTOR; SEASONAL VARIATION; SEPSIS; SEPTIC SHOCK; SEX RATIO; SOCIAL STATUS; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; UROGENITAL TRACT INFECTION;

COST OF ILLNESS; FEMALE; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMANS; MALE; RISK FACTORS; SEASONS; SEPSIS; SHOCK, SEPTIC;

EID: 48249115932     PISSN: 13816128     EISSN: None     Source Type: Journal    
DOI: 10.2174/138161208784980590     Document Type: Review

References (54)

1. Majno G. The ancient riddle of sigma eta psi iota sigma (sepsis). J Infect Dis 1991; 163(5): 937-45.
2. Vincent JL, Abraham E. The last 100 years of sepsis. Am J Respir Crit Care Med 2006; 173(3): 256-63.
3. Baron RM, Baron MJ, Perrella MA. Pathobiology of sepsis: Are we still asking the same questions? Am J Respir Cell Mol Biol 2006; 34(2): 129-34.
4. Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 1992; 101(6): 1644-55.
5. Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR. Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care. Crit Care Med 2001; 29(7): 1303-10.
6. Brun-Buisson C, Meshaka P, Pinton P, Vallet B. EPISEPSIS: A reappraisal of the epidemiology and outcome of severe sepsis in French intensive care units. Intensive Care Med 2004; 30(4): 580-8.
7. Guidet B, Aegerter P, Gauzit R, Meshaka P, Dreyfuss D. Incidence and impact of organ dysfunctions associated with sepsis. Chest 2005; 127(3): 942-51.
8. Rangel-Frausto MS, Pittet D, Costigan M, Hwang T, Davis CS, Wenzel RP. The natural history of the systemic inflammatory response syndrome (SIRS). A prospective study. JAMA 1995; 273(2): 117-23.
9. Pittet D, Rangel-Frausto S, Li N, Tarara D, Costigan M, Rempe L, et al. Systemic inflammatory response syndrome, sepsis, severe sepsis and septic shock: Incidence, morbidities and outcomes in surgical ICU patients. Intensive Care Med 1995; 21(4): 302-9.
10. Martin GS, Mannino DM, Eaton S, Moss M. The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med 2003; 348(16): 1546-54.
11. Padkin A, Goldfrad C, Brady AR, Young D, Black N, Rowan K. Epidemiology of severe sepsis occurring in the first 24 hrs in intensive care units in England, Wales, and Northern Ireland. Crit Care Med 2003; 31(9): 2332-28.
12. Moss M. Epidemiology of sepsis: Race, sex, and chronic alcohol abuse. Clin Infect Dis 2005; 41 Suppl 7: S490-7.
13. Dombrovskiy VY, Martin AA, Sunderram J, Paz HL. Facing the challenge: decreasing case fatality rates in severe sepsis despite increasing hospitalizations. Crit Care Med 2005; 33(11): 2555-62.
14. Finfer S, Bellomo R, Lipman J, French C, Dobb G, Myburgh J. Adult-population incidence of severe sepsis in Australian and New Zealand intensive care units. Intens Care Med 2004; 30(4): 589-96.
15. Baum M. The changing face of breast cancer-past present and future perspectives. Breast Cancer Res Treat 2002; 75(Suppl 1): S1-5.
16. Piot P, Bartos M, Ghys PD, Walker N, Schwartlander B. The global impact of HIV/AIDS. Nature 200 1; 410(6831): 968-73.
17. Alberti C, Brun-Buisson C, Burchardi K Martin C, Goodman S, Artigas A, et al. Epidemiology of sensis and infection in ICU patients from an international multicentre cohort study. Intens Care Med 2002; 28(2): 108-21.
18. Esper AM, Moss M, Lewis CA, Nisbet R, Mannino DM, Martin GS. The role of infection and comorbidity: Factors that influence disparities in sepsis. Crit Care Med 2006; 34(10): 2576-82.
19. Cheng B, Xie G, Yao S, Wu X, Guo Q, Gu M, et al. Epidemiology of severe sepsis in critically ill surgical patients in ten university hospitals in China. Crit Care Med 2007; 35(11): 2538-46.
20. Dombrovskiy VY, Martin AA, Sunderram J, Paz HL. Occurrence and outcomes of sepsis: Influence of race. Crit Care Med 2007; 35(3): 763-8.
21. Watson RS, Carcillo JA, Linde-Zwirble WT, Clermont G, Lidicker J, Angus DC. The epidemiology of severe sepsis in children in the United States. Am J Respir Crit Care Med 2003; 167(5): 695-701.
22. Angus DC, Kelley MA, Schmitz RJ, White A, Popovich J, Jr. Caring for the critically ill patient. Current and projected workforce requirements for care of the critically ill and patients with pulmonary disease: Can we meet the requirements of an aging population? JAMA 2000; 284(21):2762-70.
23. Martin GS, Mannino DK Moss M. The effect of age on the development and outcome of adult sepsis. Crit Care Med 2006; 34(1): 15-21.
24. Andersen B, Goldsmith GK Spagnuolo PJ. Neutrophil adhesive dysfunction in diabetes mellitus; the role of cellular and plasma factors. J Lab Clin Med 1988; 111(3): 275-85.
25. Repine JE, Clawson CC, Goetz FC. Bactericidal function of neutrophils from patients with acute bacterial infections and from diabetics. J Infect Dis 1980; 142(6): 869-75.
26. Moss M, Guidot DK Steinberg KP, Duhon GF, Treece P, Wolken R, et al. Diabetic patients have a decreased incidence of acute respiratory distress syndrome. Crit Care Med 2000; 28(7): 2187-92.
27. Danai PA, Moss K Mannino DM, Martin GS. The epidemiology of sepsis in patients with malignancy. Chest 2006; 129(6): 1432-40.
28. Liu YK. Leukopenia in alcoholics. Am J Med 1973; 54(5): 605-10.
29. Sachs CW, Christensen RK Pratt PC, Lynn WS. Neutrophil elastase activity and superoxide production are diminished in neutrophils of alcoholics. Am Rev Respir Dis 1990; 141(5 Pt 1): 1249-55.
30. Mandrekar P, Catalano D, Szabo G. Inhibition of lipopolysaccharide-mediated NFkappaB activation by ethanol in human monocytes. Int Immunol 1999; 11(11): 1781-90.
31. Nelson S, Kolls JK. Alcohol, host defence and society. Nat Rev Immunol 2002; 2(3): 205-9.
32. Laurenzi GA, Guarneri JJ. Effect of bacteria and viruses on ciliated epithelium. A study of the mechanisms of pulmonary resistance to infection: The relationship of bacterial clearance to ciliary and alveolar macrophage function. Am Rev Respir Dis 1966; 93(3): Suppl-41.
33. Fernandez-Sola J, Junque A, Estruch R, Monforte R, Torres A, Urbano-Marquez A. High alcohol intake as a risk and prognostic factor for community-acquired pneumonia. Arch Intern Med 1995; 155(15): 1649-54.
34. Ortqvist A, Hedlund J, Grillner L, Jalonen E, Kallings I, Leinonen K, et al. Aetiology, outcome and prognostic factors in community-acquired pneumonia requiring hospitalization. Eur Respir J 1990; 3(10): 1105-13.
35. Carpenter JL, Huang DY. Community-acquired pulmonary infections in a public municipal hospital in the 1980s. South Med J 1991; 84(3): 299-306.
36. Saitz R, Ghali WA, Moskowitz MA. The impact of alcohol-related diagnoses on pneumonia outcomes. Arch Intern Med 1997; 157(13): 1446-52.
37. Perlino, CA, Rimland D. Alcoholism leukopenia, and pneumococcal sepsis. Am Rev Respir Dis 1985; 132(4): 757-60.
38. Rosenberg AL, Seneff MG, Atiyeh L, Wagner R, Bojanowski L, Zimmerman JE. The importance of bacterial sepsis in intensive care unit patients with acquired immunodeficiency syndrome: Implications for future care in the age of increasing antiretroviral resistance. Crit Care Med 2001; 29(3): 548-56.
39. Thyrault K Gachot B, Chastang C, Souweine B, Timsit JF, Bedos JP, et al. Septic shock in patients with the acquired immunodeficiency syndrome. Intens Care Med 1997; 23(10): 1018-23.
40. Barnato AE, Alexander SL, Linde-Zwirble WT, Angus DC. Racial variation in the incidence, care, and outcomes of severe sepsis: Analysis of population, patient, and hospital characteristics. Am J Respir Crit Care Med 2008; 177(3): 279-84.
41. Isaacs SL, Schroeder SA. Class - the ignored determinant of the nation's health. N Engl J Med 20041 351(11): 1137-42.
42. Marmot M. Social determinants of keidih inequalities. Lancet 2005; 365(9464): 1099-104.
43. Danis M, Linde-Zwirble. WT, Astor A, Lidicker JR, Angus DC. How does lack of insurance affect use of intensive care? A population-based study. Crit Care Med 2006; 34(8): 2043-8.
44. Peckova M, Fahrenbruch CE, Cobb LA, Hallstrom AP. Weekly and seasonal variation in the incidence of cardiac arrests. Am Heart J 1999; 137(3): 512-5.
45. Lanska DJ, Hoffmann RG. Seasonal variation in stroke mortality rates. Neurology 1999; 52(5): 984-90.
46. Danai PA, Sinha S, Moss K Haber MJ, Martin GS. Seasonal variation in the epidemiology of sepsis. Crit Care Med 2007; 35(2): 410-5.
47. Williams MD, Braun LA, Cooper LM, Johnston J, Weiss RV, Qualy RL, et al. Hospitalized cancer patients with severe sepsis: Analysis of incidence, mortality, and associated costs of care. Crit Care 2004; 8(5): R291-8.
48. Letarte J, Longo CJ, Pelletier J, Nabonne B, Fisher HN. Patient characteristics and costs of severe sepsis and septic shock in Quebec. J Crit Care 2002; 17(1): 39-49.
49. Perl TM, Dvorak L, Hwang T, Wenzel RP. Long-term survival and function after suspected gram-negative sepsis. JAMA 1995; 274(4): 338-45.
50. Quartin AA, Schein RM, Kett DH, Peduzzi PN. Magnitude and duration of the effect of sepsis on survival. Department of Veterans Affairs Systemic Sepsis Cooperative Studies Group. JAMA 1997; 277(13): 1058-63.
51. Weycker D, Akhras KS, Edelsberg J, Angus DC, Oster G. Long-term mortality and medical care charges in patients with severe sepsis. Crit Care Med 2003; 3(9): 2316-23.
52. de la Lastra CA, Villegas I, Sanchez-Fidalgo S. Poly(ADP-ribose) polymerase inhibitors: New pharmacological functions and potential clinical implications. Curr Pharm Des 2007; 13(9): 933-62.
53. Gonzalez-Rey E, Varela N, Chorny A, Delgado M. Therapeutical approaches of vasoactive intestinal peptide as a pleiotropic immunomodulator. Curr Pharm Des 2007; 13(11): 1113-39.
54. Victor VM, Rocha M. Targeting antioxidants to mitochondria: A potential new therapeutic strategy for cardiovascular diseases. Curr Pharm Des 2007; 13(8): 845-63.